Bibliometric analysis highlights research on type 2 diabetes and its connection to microalgal bioactives, suggesting potential therapeutic avenues.
Type 2 diabetes mellitus (T2DM) is recognized as a multifactorial health disorder associated with various complications. This paper presents a bibliometric analysis of type 2 diabetes mellitus and natural active substances. Currently, the research field in this area is on an upward trajectory, with major research hotspots focusing on pathogenesis, pharmacological activities, the gut microbiota, and lipid metabolism. Algae-derived natural active substances, namely astaxanthin, extracellular polysaccharide from Porphyridium cruentum (EPS-P), and β-carotene, all exhibit high antioxidant properties and safety, along with favorable hypoglycemic effects. Therefore, their therapeutic intervention effects on type 2 diabetes mellitus were evaluated through in vitro experiments. Compared with the model group, astaxanthin, β-carotene, and Porphyridium cruentum polysaccharide (EPS-P) improved various indicators by at least 24.17%, 7.7%, and 6.7%, respectively. All three substances could, to a certain extent, enhance glucose consumption, glycogen content, and pyruvate activity, as well as improve and restore the condition of IR-HepG2 cells. The order of intervention efficacy was astaxanthin, followed by β-carotene, and then Porphyridium cruentum polysaccharide (EPS-P). These findings provide a scientific basis for the biomedical applications of algae-derived natural products.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: